AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30969332 — intervention group
Group type: EXPERIMENTAL
Intervention: bell on (use-tracking IS reminder)
Number of subjects: 145
Study 30969332 — intervention group
Group type: COMPARATOR
Intervention: bell off (control group)
Number of subjects: 145
Study 30451718 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education by a clinical pharmacist on correct patch administration
Number of subjects: 23
Study 30451718 — intervention group
Group type: COMPARATOR
Intervention: Routine counseling during patient-physician consultation (Control)
Number of subjects: 23
Study 26729157 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 Index
Number of subjects: 266
Study 24621348 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain Shirota (LcS) - 40 billion per day for 4 weeks
Number of subjects: 134
Study 24621348 — intervention group
Group type: COMPARATOR
Intervention: Placebo - one bottle per day for 4 weeks
Number of subjects: 134
Study 21575967 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone plus dutasteride
Number of subjects: 53
Study 21575967 — intervention group
Group type: COMPARATOR
Intervention: Testosterone only
Number of subjects: 53
Study 19186718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture compound anesthesia
Number of subjects: 700
Study 19186718 — intervention group
Group type: COMPARATOR
Intervention: Simple Dolantin
Number of subjects: 700
Study 16801302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (exact dosage and duration not specified)
Number of subjects: 1347
Study 16801302 — intervention group
Group type: COMPARATOR
Intervention: Screening protocol for eligibility
Number of subjects: 1347
Study 12766829 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol-containing vaginal pessary (0.5 mg estriol) twice weekly
Number of subjects: 171
Study 12766829 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin macrocrystal (100 mg) once daily
Number of subjects: 171
Study 12766829 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol-containing vaginal pessary
Number of subjects: 171
Study 12766829 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin macrocrystal
Number of subjects: 171
Study 11314355 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi Purpose (SMP)
Number of subjects: 0
Study 11314355 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB)
Number of subjects: 0
Study 11314355 — intervention group
Group type: EXPERIMENTAL
Intervention: Syntac Single Component (Syntac)
Number of subjects: 0
Study 11314355 — intervention group
Group type: EXPERIMENTAL
Intervention: SMIP
Number of subjects: 0
Study 9109755 — intervention group
Group type: EXPERIMENTAL
Intervention: Transillumination measurements
Number of subjects: 479
Study 9109755 — intervention group
Group type: COMPARATOR
Intervention: Histologic slide measurements
Number of subjects: 479
Study 1498532 — intervention group
Group type: EXPERIMENTAL
Intervention: gu chi wan (tooth firming pills) 4 mg twice daily for 3‐6 months combined with spiramycin 0.2 four times daily for 5 days and routine periodontal treatment
Number of subjects: 90
Study 1498532 — intervention group
Group type: COMPARATOR
Intervention: spiramycin 0.2 four times daily for 5 days combined with routine periodontal treatment
Number of subjects: 90
Study 1498532 — intervention group
Group type: EXPERIMENTAL
Intervention: gu chi wan (tooth firming pills)
Number of subjects: 90
Study 3701513 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron therapy (experimental group)
Number of subjects: 25
Study 3701513 — intervention group
Group type: COMPARATOR
Intervention: Control group matched for mother's educational level
Number of subjects: 25
Study 3701513 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron therapy (iron-deficient not anemic group, n = 22)
Number of subjects: 25
Study 3701513 — intervention group
Group type: COMPARATOR
Intervention: Control group for iron-deficient not anemic group
Number of subjects: 25
Study 3701513 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (iron-deficient not anemic group, n = 23)
Number of subjects: 25
Study 3701513 — intervention group
Group type: COMPARATOR
Intervention: Control group for placebo (iron-deficient not anemic group)
Number of subjects: 25
Study 3701513 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral rating data (iron-deficient anemic group)
Number of subjects: 25
Study 3701513 — intervention group
Group type: COMPARATOR
Intervention: Control group for behavioral rating data
Number of subjects: 25
Study 31243192 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII + liraglutide
Number of subjects: 60
Study 31243192 — intervention group
Group type: COMPARATOR
Intervention: CSII
Number of subjects: 60
Study 28646940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradetrusor injection of botulinum toxin type A (BTX‐A) 100 U
Number of subjects: 60
Study 28646940 — intervention group
Group type: COMPARATOR
Intervention: Posterior tibial nerve stimulation (PTNS)
Number of subjects: 60
Study 28646940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradetrusor injection of botulinum toxin type A (BTX‐A)
Number of subjects: 60
Study 27163420 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem infusion (2.5 microgram/kg/min)
Number of subjects: 140
Study 27163420 — intervention group
Group type: COMPARATOR
Intervention: No diltiazem infusion
Number of subjects: 140
Study 27163420 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem infusion
Number of subjects: 140
Study 23038174 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain barley (WGB)
Number of subjects: 28
Study 23038174 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice (BR)
Number of subjects: 28
Study 23038174 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal mixture of whole-grain barley and brown rice (BR+WGB)
Number of subjects: 28
Study 22180525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 22180525 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin D supplementation)
Number of subjects: 0
Study 18998205 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D scapulothoracic motion assessment during scaption on affected side
Number of subjects: 152
Study 18998205 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder Pain and Disability Index (SPADI) assessment
Number of subjects: 152
Study 18998205 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of pain and dysfunction levels post-surgery
Number of subjects: 152
Study 18998205 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of left vs right side affected patients
Number of subjects: 152
Study 18998205 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of altered movement patterns
Number of subjects: 152
Study 16942968 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping With Depression Course (CWDC)
Number of subjects: 0
Study 16942968 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 15093845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac tromethamine (0.5 mg/kg, max 30 mg)
Number of subjects: 40
Study 15093845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15093845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac tromethamine
Number of subjects: 40
Study 11252058 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion for 60 seconds
Number of subjects: 24
Study 11252058 — intervention group
Group type: COMPARATOR
Intervention: 1 x 60-s hold
Number of subjects: 24
Study 11252058 — intervention group
Group type: COMPARATOR
Intervention: 2 x 30-s holds
Number of subjects: 24
Study 11252058 — intervention group
Group type: COMPARATOR
Intervention: 4 x 15-s holds
Number of subjects: 24
Study 11252058 — intervention group
Group type: COMPARATOR
Intervention: 0-s hold (baseline)
Number of subjects: 24
Study 9048403 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg/day continued prophylaxis, N = 90
Number of subjects: 179
Study 9048403 — intervention group
Group type: COMPARATOR
Intervention: Placebo, N = 89
Number of subjects: 179
Study 7880461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Mint Listerine Antiseptic mouthrinse
Number of subjects: 36
Study 7880461 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 3537545 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrotide
Number of subjects: 80
Study 3537545 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole
Number of subjects: 80
Study 30347780 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain intake
Number of subjects: 136
Study 30347780 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in whole fruit intake
Number of subjects: 136
Study 30347780 — intervention group
Group type: EXPERIMENTAL
Intervention: Added sugar intake
Number of subjects: 136
Study 30347780 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fat intake
Number of subjects: 136
Study 30347780 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated fat intake
Number of subjects: 136
Study 27084247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose CVVHDF (80mL/kg/h)
Number of subjects: 212
Study 27084247 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose CVVHDF (40mL/kg/h)
Number of subjects: 212
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A: 3 cycles of epirubicin 110 mg/m2 followed by 3 cycles of paclitaxel 200 mg/m2 followed by 3 cycles of intensified CMF
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B: 3 cycles of epirubicin followed by 3 cycles of CMF, then 9 weekly cycles of docetaxel 35 mg/m2
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm C: 9 weekly cycles of paclitaxel 80 mg/m2
Number of subjects: 1001
Study 25026897 — intervention group
Group type: COMPARATOR
Intervention: Combined Arms B and C
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B
Number of subjects: 1001
Study 25026897 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients receiving trastuzumab
Number of subjects: 1001
Study 23039143 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the bilateral subthalamic nucleus (STN) or globus pallidus internus (GPi)
Number of subjects: 29
Study 23039143 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 29
Study 23039143 — intervention group
Group type: COMPARATOR
Intervention: Healthy control volunteers (CTRL group)
Number of subjects: 29
Study 23039143 — intervention group
Group type: COMPARATOR
Intervention: PD control volunteers (PD-C group)
Number of subjects: 29
Study 21250772 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating-rotating electric toothbrush
Number of subjects: 20
Study 21250772 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 20
Study 18420714 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT: 3/wk x 12 wk)
Number of subjects: 36
Study 18420714 — intervention group
Group type: COMPARATOR
Intervention: Electrical Stimulation (ES: 1 h/day x 12 wk)
Number of subjects: 36
Study 18420714 — intervention group
Group type: COMPARATOR
Intervention: Standard Rehabilitation (SR: 1 h/day x 12 wk)
Number of subjects: 36
Study 16831228 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 217
Study 16831228 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated GPs
Number of subjects: 217
Study 16831228 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination among young GPs
Number of subjects: 217
Study 16831228 — intervention group
Group type: EXPERIMENTAL
Intervention: Low basic antibody titre against influenza
Number of subjects: 217
Study 16831228 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of influenza cases in the family
Number of subjects: 217
Study 12625310 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.25 microg x kg(‐1) x min(‐1))
Number of subjects: 155
Study 12625310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (40 mg)
Number of subjects: 155
Study 12625310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 12625310 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil vs Placebo
Number of subjects: 155
Study 12625310 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine vs Placebo
Number of subjects: 155
Study 12625310 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil vs Lidocaine
Number of subjects: 155
Study 10703660 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra-gingival oral irrigation plus routine oral hygiene (ROH) for 14 days
Number of subjects: 52
Study 10703660 — intervention group
Group type: COMPARATOR
Intervention: Routine oral hygiene (ROH) for 14 days
Number of subjects: 52
Study 10703660 — intervention group
Group type: COMPARATOR
Intervention: No oral hygiene for 14 days
Number of subjects: 52
Study 9169577 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 12
Study 9169577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1350192 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 200
Study 1350192 — intervention group
Group type: COMPARATOR
Intervention: Auranofin
Number of subjects: 200
Study 1350192 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 200
Study 3903013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 70
Study 3903013 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 70
Study 29737599 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Positive Behavioural Support (PBS)
Number of subjects: 50
Study 29737599 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-randomized)
Number of subjects: 50
Study 26625939 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy protocol with supervised usage of adaptive devices (n=20)
Number of subjects: 40
Study 26625939 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy (n=20)
Number of subjects: 40
Study 24439983 — intervention group
Group type: EXPERIMENTAL
Intervention: epoprostenol AM
Number of subjects: 30
Study 24439983 — intervention group
Group type: COMPARATOR
Intervention: epoprostenol GM
Number of subjects: 30
Study 22369176 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment containing a seaweed-derived oligosaccharide complexed with 0.1% zinc pyrrolidone
Number of subjects: 60
Study 22369176 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 60
Study 20357238 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation
Number of subjects: 28
Study 20357238 — intervention group
Group type: COMPARATOR
Intervention: Standard chest physiotherapy
Number of subjects: 28
Study 18402631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 26
Study 18402631 — intervention group
Group type: COMPARATOR
Intervention: Discontinuing mood stabilizers
Number of subjects: 26
Study 15932569 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 x 5 Gy irradiation (5 fractions of 5 Gy)
Number of subjects: 305
Study 15932569 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation (50.4 Gy, 1.8 Gy per fraction plus bolus 5‐fluorouracil and leucovorin)
Number of subjects: 305
Study 12913705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 121
Study 12913705 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS)
Number of subjects: 121
Study 12913705 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 121
Study 12913705 — intervention group
Group type: COMPARATOR
Intervention: Control (no PPS)
Number of subjects: 121
Study 10408405 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 1000 mg m‐2 intravenous (i.v.) weekly for 3 weeks out of every 4 and 5‐fluorouracil (5‐FU) 600 mg m‐2 bolus i.v. weekly for 3 weeks out of every 4
Number of subjects: 54
Study 7551201 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy with high doses of Parietaria extract (cumulative dose of 105 BU)
Number of subjects: 31
Study 7551201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 1763422 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training for remembering names and faces (treatment duration: one month, twice weekly)
Number of subjects: 14
Study 1763422 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (control group)
Number of subjects: 14
Study 6123089 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 59
Study 6123089 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate sodium (VPA)
Number of subjects: 59
Study 29847188 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MLD and vibrotherapy treatment
Number of subjects: 30
Study 29847188 — intervention group
Group type: COMPARATOR
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 30
Study 30522919 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial representation of carotid ultrasound plus a nurse phone call to confirm understanding
Number of subjects: 3532
Study 30522919 — intervention group
Group type: COMPARATOR
Intervention: Not informed (control group)
Number of subjects: 3532
Study 30060787 — intervention group
Group type: COMPARATOR
Intervention: Standard parachute technique
Number of subjects: 56
Study 30060787 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamond-shaped anastomosis technique
Number of subjects: 56
Study 27181130 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 25127325 — intervention group
Group type: EXPERIMENTAL
Intervention: FS4
Number of subjects: 33
Study 25127325 — intervention group
Group type: EXPERIMENTAL
Intervention: FS4-p
Number of subjects: 33
Study 25127325 — intervention group
Group type: COMPARATOR
Intervention: FSP
Number of subjects: 33
Study 22415479 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 1087
Study 22415479 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 25 kg/m(2)
Number of subjects: 1087
Study 22415479 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal 25OHD (<72 nmol/l)
Number of subjects: 1087
Study 22415479 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD, insulin, CRP, and leptin levels as continuous variables
Number of subjects: 1087
Study 19329013 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL 2% lidocaine
Number of subjects: 56
Study 19329013 — intervention group
Group type: COMPARATOR
Intervention: 5 mL normal saline (control group)
Number of subjects: 56
Study 17584700 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) with Gaussian kernel using 9 parameters and FIR filter
Number of subjects: 376
Study 17584700 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) with Gaussian kernel using 3 standard parameters and Butterworth filter
Number of subjects: 376
Study 17584700 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) with Gaussian kernel using 9 parameters and Butterworth filter
Number of subjects: 376
Study 15177835 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy living booklet
Number of subjects: 252
Study 15177835 — intervention group
Group type: COMPARATOR
Intervention: Patient satisfaction questionnaire
Number of subjects: 252
Study 12174106 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 2.5 mg kg(‐1) day(‐1)
Number of subjects: 37
Study 12174106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 12174106 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 37
Study 9400430 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm. mycophenolate mofetil twice daily
Number of subjects: 491
Study 9400430 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 gm. mycophenolate mofetil twice daily
Number of subjects: 491
Study 9400430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study 7658314 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 U/kg rhEPO three times a week
Number of subjects: 48
Study 7658314 — intervention group
Group type: COMPARATOR
Intervention: 450 U/kg rhEPO two times a week
Number of subjects: 48
Study 2468141 — intervention group
Group type: EXPERIMENTAL
Intervention: New algorithm for QT sensing rate responsive pacemaker
Number of subjects: 10
Study 729378 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive with synthetic estrogen (ethinyl estradiol)
Number of subjects: 0
Study 729378 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive with natural estrogens (micronized estradiol and estriol)
Number of subjects: 0
Study 31126220 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-light display temporal occlusion training with motor practice of the observed bowler's action, 2 sessions per week for 4 weeks
Number of subjects: 12
Study 31126220 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-light display temporal occlusion training with motor practice of the observed bowler's action
Number of subjects: 12
Study 31126220 — intervention group
Group type: COMPARATOR
Intervention: Control group (only testing phases)
Number of subjects: 12
Study 28437539 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose valganciclovir hydrochloride (n=46)
Number of subjects: 124
Study 28437539 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir hydrochloride (n=34)
Number of subjects: 124
Study 28437539 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention (n=44)
Number of subjects: 124
Study 26453041 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based computer-tailored physical activity intervention (seven 10- to 15-min sessions over an 8-week period)
Number of subjects: 244
Study 26453041 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 244
Study 23559332 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU/day
Number of subjects: 169